SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001021408-03-004211
Filing Date
2003-03-13
Accepted
2003-03-13 14:49:04
Documents
8
Period of Report
2003-03-12
Items
Item 5: Other events
Item 7: Financial statements and exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.txt 8-K 7716
3 PRESS RELEASE dex991.txt EX-99.1 3703
4 PRESS RELEASE dex992.txt EX-99.2 3324
5 COMMON STOCK PURCHASE AGREEMENT dex993.txt EX-99.3 62436
6 2ND ADDENDUM TO REGISTRATION RIGHTS AGREEMENT dex994.txt EX-99.4 4021
7 LETTER AGREEMENTS dex995.txt EX-99.5 8550
8 AMENDMENT NO. 3 TO RIGHTS AGREEMENT dex996.txt EX-99.6 5472
9 OFFICER'S CERTIFICATE dex997.txt EX-99.7 2456
  Complete submission text file 0001021408-03-004211.txt   100345
Mailing Address 137 NEWBURY STREET 8TH FLOOR BOSTON MA 02116
Business Address 137 NEWBURY STREET 8TH FLOOR BOSTON MA 02116 6174250200
BOSTON LIFE SCIENCES INC /DE (Filer) CIK: 0000094784 (see all company filings)

IRS No.: 870277826 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-06533 | Film No.: 03602265
SIC: 2834 Pharmaceutical Preparations